Ultrasound molecular imaging of transient acute myocardial ischemia with a clinically translatable P- and E-selectin targeted contrast agent: Correlation with the expression of selectins

Investigative Radiology

Volumn 49, Issue 4, 2014, Pages 224-235

  Hyvelin, Jean Marc ^a   Tardy, Isabelle ^a   Bettinger, Thierry ^a   Von Wronski, Mathew ^a   Costa, Maria ^a   Emmel, Patricia ^a   Colevret, Delphine ^a   Bussat, Philippe ^a   Lassus, Anne ^a   Botteron, Catherine ^a   Nunn, Adrian ^a   Frinking, Peter ^a   Tranquart, François ^a  

^a Bracco Suisse SA   (Switzerland)

Author keywords

inflammation; molecular imaging; myocardial ischemia memory; selectin; ultrasound contrast agent

Indexed keywords

ECHO CONTRAST MEDIUM; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; PADGEM PROTEIN; STREPTAVIDIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTRAST ENHANCEMENT; CONTROLLED STUDY; ECHOCARDIOGRAPHY; HEART LEFT VENTRICLE; HEART MUSCLE ISCHEMIA; HEART MUSCLE REPERFUSION; IMAGE ENHANCEMENT; IMMUNOHISTOCHEMISTRY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MICROBUBBLE; MOLECULAR IMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TISSUE NECROSIS; TRANSIENT ACUTE MYOCARDIAL ISCHEMIA; ULTRASOUND SCANNER;

ANIMALS; ANTIBODIES, MONOCLONAL; BIOLOGICAL MARKERS; CONTRAST MEDIA; E-SELECTIN; MICROBUBBLES; MOLECULAR IMAGING; MYOCARDIAL REPERFUSION INJURY; P-SELECTIN; RATS; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; STATISTICS AS TOPIC; ULTRASONOGRAPHY;

EID: 84896319406     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0000000000000018     Document Type: Article

References (48)

1. Go AS, Mozaffarian D, Roger VL, et al. Heart disease and stroke statisticsV2013 update: A report from the American Heart Association. Circulation. 2013;127:e6Ye245
2. Pope JH, Aufderheide TP, Ruthazer R, et al. Missed diagnoses of acute cardiac ischemia in the emergency department. N Engl J Med. 2000;342:1163-1170
3. Hamm CW, Bassand JP, Agewall S, et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent STsegment elevation: The Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J. 2011;32: 2999-3054
4. Lev EI, Battler A, Behar S, et al. Frequency, characteristics, and outcome of patients hospitalized with acute coronary syndromes with undetermined electrocardiographic patterns. Am J Cardiol. 2003;91:224-227
5. Ahmed AH, Shankar K, Eftekhari H, et al. Silent myocardial ischemia: Current perspectives and future directions. Exp Clin Cardiol. 2007;12:189-196
6. Gutterman DD. Silent myocardial ischemia. Circ J. 2009;73:785-797
7. Conti CR, Bavry AA, Petersen JW. Silent ischemia: Clinical relevance. J Am Coll Cardiol. 2012;59:435-441
8. Keller T, Zeller T, Peetz D, et al. Sensitive troponin I assay in early diagnosis of acute myocardial infarction. N Engl J Med. 2009;361:868-877
9. Haaf P, Drexler B, Reichlin T, et al. High-sensitivity cardiac troponin in the distinction of acute myocardial infarction from acute cardiac noncoronary artery disease. Circulation. 2012;126:31-40
10. Bluemke DA, Achenbach S, Budoff M, et al. Noninvasive coronary artery imaging: Magnetic resonance angiography and multidetector computed tomography angiography: A scientific statement from the American Heart Association committee on cardiovascular imaging and intervention of the council on cardiovascular radiology and intervention, and the councils on clinical cardiology and cardiovascular disease in the young. Circulation. 2008;118:586-606
11. Kwong RY, Schussheim AE, Rekhraj S, et al. Detecting acute coronary syndrome in the emergency department with cardiac magnetic resonance imaging. Circulation. 2003;107:531-537
12. Hoffmann U, Bamberg F, Chae CU, et al. Coronary computed tomography angiography for early triage of patients with acute chest pain: The ROMICAT (rule out myocardial infarction using computer assisted tomography) trial. J Am Coll Cardiol. 2009;53:1642-1650
13. Cheitlin MD, Armstrong WF, Aurigemma GP, et al. ACC/AHA/ASE 2003 guideline update for the clinical application of echocardiography: Summary article: A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (ACC/AHA/ASE Committee to Update the 1997 Guidelines for the Clinical Application of Echocardiography). Circulation. 2003;108:1146-1162
14. Sabia P, Afrookteh A, Touchstone DA, et al. Value of regional wall motion abnormality in the emergency room diagnosis of acute myocardial infarction. A prospective study using two-dimensional echocardiography. Circulation. 1991;84:I85YI92
15. Jeetley P, Burden L, Greaves K, et al. Prognostic value of myocardial contrast echocardiography in patients presenting to hospital with acute chest pain and negative troponin. Am J Cardiol. 2007;99:1369-1373
16. Senior R, Monaghan M, Main ML, et al. Detection of coronary artery disease with perfusion stress echocardiography using a novel ultrasound imaging agent: Two phase 3 international trials in comparison with radionuclide perfusion imaging. Eur J Echocardiogr. 2009;10:26-35
17. Lindner JR. Contrast ultrasound molecular imaging of inflammation in cardiovascular disease. Cardiovasc Res. 2009;84:182-189
18. Kiessling F, Fokong S, Koczera P, et al. Ultrasound microbubbles for molecular diagnosis, therapy, and theranostics. J Nucl Med. 2012;53:345-348
19. Klibanov AL. Ligand-carrying gas-filled microbubbles: Ultrasound contrast agents for targeted molecular imaging. Bioconjug Chem. 2005;16:9-17
20. Leong-Poi H, Christiansen J, Heppner P, et al. Assessment of endogenous and therapeutic arteriogenesis by contrast ultrasound molecular imaging of integrin expression. Circulation. 2005;111:3248-3254
21. Kaufmann BA, Sanders JM, Davis C, et al. Molecular imaging of inflammation in atherosclerosis with targeted ultrasound detection of vascular cell adhesion molecule-1. Circulation. 2007;116:276-284
22. Liu Y, Davidson BP, Yue Q, et al. Molecular imaging of inflammation and platelet adhesion in advanced atherosclerosis effects of antioxidant therapy with NADPH oxidase inhibition. Circ Cardiovasc Imaging. 2013;6:74-82
23. Krieglstein CF, Granger DN. Adhesion molecules and their role in vascular disease. Am J Hypertens. 2001;14:44SY54S.
24. Weller GE, Villanueva FS, Tom EM, et al. Targeted ultrasound contrast agents: In vitro assessment of endothelial dysfunction and multi-Targeting to ICAM-1 and sialyl Lewisx. Biotechnol Bioeng. 2005;92:780-788
25. McCarty OJ, Conley RB, Shentu W, et al. Molecular imaging of activated von Willebrand factor to detect high-risk atherosclerotic phenotype. JACC Cardiovasc imaging. 2010;3:947-955
26. Lindner JR, Song J, Christiansen J, et al. Ultrasound assessment of inflammation and renal tissue injury with microbubbles targeted to P-selectin. Circulation. 2001;104:2107-2112
27. Davidson BP, Kaufmann BA, Belcik JT, et al. Detection of antecedent myocardial ischemia with multiselectin molecular imaging. J Am Coll Cardiol. 2012;60:1690-1697
28. Villanueva FS, Wagner WR. Ultrasound molecular imaging of cardiovascular disease. Nat Clin Pract Cardiovasc Med. 2008;5(suppl 2):S26YS32
29. Yan Y, Liao Y, Yang L, et al. Late-phase detection of recent myocardial ischaemia using ultrasound molecular imaging targeted to intercellular adhesion molecule-1. Cardiovasc Res. 2011;89:175-183
30. Ley K, Bullard DC, Arbones ML, et al. Sequential contribution of L-And Pselectin to leukocyte rolling in vivo. J Exp Med. 1995;181:669-675
31. Rychak JJ, Li B, Acton ST, et al. Selectin ligands promote ultrasound contrast agent adhesion under shear flow. Mol Pharm. 2006;3:516-524
32. Schneider M, Broillet A, Tardy I, et al. Use of intravital microscopy to study the microvascular behavior of microbubble-based ultrasound contrast agents. Microcirculation. 2012;19:245-259
33. Villanueva FS, Lu E, Bowry S, et al. Myocardial ischemic memory imaging with molecular echocardiography. Circulation. 2007;115:345-352
34. Bettinger T, Bussat P, Tardy I, et al. Ultrasound molecular imaging contrast agent binding to both E-And P-selectin in different species. Invest Radiol. 2012;47:516-523
35. Wang H, Machtaler S, Bettinger T, et al. Molecular imaging of inflammation in inflammatory bowel disease with a clinically translatable dual-selectin-Targeted US contrast agent: Comparison with FDG PET/CT in a mouse model. Radiology. 2013;267:818-829
36. Schlecht-Bauer D, Antier D, Machet MC, et al. Short-And long-Term cardioprotective effect of darbepoetin-Alpha: Role of Bcl-2 family proteins. J Cardiovasc Pharmacol. 2009;54:223-231
37. Schneider M, Anantharam B, Arditi M, et al. BR38, a new ultrasound blood pool agent. Invest Radiol. 2011;46:486-494
38. Kumar R, Camphausen RT, Sullivan FX, et al. Core2 beta-1,6- Nacetylglucosaminyltransferase enzyme activity is critical for P-selectin glycoprotein ligand-1 binding to P-selectin. Blood. 1996;88:3872-3879
39. Hyvelin JM, Tardy I, Arbogast C, et al. Use of ultrasound contrast agent microbubbles in preclinical research: Recommendations for small animal imaging. Invest Radiol. 2013;48:570-583
40. Kaufmann BA, Lindner JR. Molecular imaging with targeted contrast ultrasound. Curr Opin Biotechnol. 2007;18:11-16
41. Eppihimer MJ,Wolitzky B, Anderson DC, et al. Heterogeneity of expression of E-And P-selectins in vivo. Circ Res. 1996;79:560-569
42. Henseleit U, Steinbrink K, Goebeler M, et al. E-selectin expression in experimental models of inflammation in mice. J Pathol. 1996;180:317-325
43. McEver RP, Beckstead JH, Moore KL, et al. GMP-140, a platelet alpha-granule membrane protein, is also synthesized by vascular endothelial cells and is localized in Weibel-Palade bodies. J Clin Invest. 1989;84:92-99
44. Gosk S,Moos T, Gottstein C, et al. VCAM-1 directed immunoliposomes selectively target tumor vasculature in vivo. Biochim Biophys Acta. 2008;1778:854-863
45. Tardif JC, Tanguay JF, Wright SS, et al. Effects of the P-selectin antagonist inclacumab on myocardial damage after percutaneous coronary intervention for non-ST-segment elevation myocardial infarction: Results of the SELECTACS Trial. J Am Coll Cardiol. 2013;61:2048-2055
46. Hillis GS, Terregino C, Taggart P, et al. Elevated soluble P-selectin levels are associated with an increased risk of early adverse events in patients with presumed myocardial ischemia. Am Heart J. 2002;143:235-241
47. Jaakkola K, Jalkanen S, Kaunismaki K, et al. Vascular adhesion protein-1, intercellular adhesion molecule-1 and P-selectin mediate leukocyte binding to ischemic heart in humans. J Am Coll Cardiol. 2000;36:122-129
48. Valen G, Paulsson G, Bennet AM, et al. Gene expression of inflammatory mediators in different chambers of the human heart. Ann Thorac Surg. 2000;70:562-567